BELVIN MARCIA (SVP, Chief Scientific Officer) sold 9.5% of their position (31.49K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $202.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2026ACC: 0001610717-26-000123
Officer· SVP, Chief Scientific Officer
Since Feb 2026
-31.49K
Net shares
Net seller
$202.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
31.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−31.49K
Price / share
$6.42
Trade value
$202.27K
% of position
9.5%
3/17/2026
332.25K→300.76K
Total
Net shares
−31.49K
Net value
-$202.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −31.49K | $6.42 | $202.27K | 9.5% | 332.25K | 300.76K |
| Total | −31.49K | -$202.27K | ||||||
Derivative Transactions0
No derivative transactions reported